Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C9H10INO2 |
| Molecular Weight | 295.0873 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC1=CC=C([131I])C=C1)C(O)=O
InChI
InChIKey=PZNQZSRPDOEBMS-WPUCPVGPSA-N
InChI=1S/C9H10INO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1/i10+4
| Molecular Formula | C9H10INO2 |
| Molecular Weight | 295.0873 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20495012
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20495012
The labeled 4-IODOPHENYLALANINE I-131 is used for proteomics research. It’s also can be used for the chemoselective modification of proteins.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Site-directed spin labelling of proteins by Suzuki-Miyaura coupling via a genetically encoded aryliodide amino acid. | 2019-02-07 |
|
| An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine. | 2011-10 |
|
| Site-specific incorporation of 4-iodo-L-phenylalanine through opal suppression. | 2010-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:10:09 GMT 2025
by
admin
on
Mon Mar 31 21:10:09 GMT 2025
|
| Record UNII |
606VTF676Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
328710
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/06/363
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50227462
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
12905
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
606VTF676Y
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
11022798
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
100000178211
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
SUB193819
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
76641-05-9
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY | |||
|
C206926
Created by
admin on Mon Mar 31 21:10:09 GMT 2025 , Edited by admin on Mon Mar 31 21:10:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
NON-LABELED -> LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|